IL-10/STAT5軸は,RAW264.7細胞におけるB7-H4発現を上調するためにmiR-140を抑制する
Dandan Zhu1, Guo Chen1,2, Pei Shen3
1Department of Pathogen Biology, School of Medicine, Nantong University, Nantong, Jiangsu, China.
Frontiers in cellular and infection microbiology
|September 2, 2025
まとめ
インターリューキン10 (IL-10) は,STAT5経由でmiR-140を抑制し,マクロファージのB7- H4発現を増加させます. これは,シストソミアシスにおける,IL-10によるB7-H4アップレギュレーションの新しいメカニズムを示しています.
科学分野:
- 免疫学
- 分子生物学
- 寄生虫学
背景:
- スキストソミアシス・ジャポニカは 炎症と免疫抑制の共存による 複雑な免疫調節を伴う.
- B7-H4は T細胞の活性化を抑制する免疫チェックポイント分子です.
- 以前の研究では,B7-H4 mRNAが感染したマウスで上昇し,B7-H4発現の強化におけるIL-10の役割が示されました.
研究 の 目的:
- マクロファージにおけるIL-10媒介のB7-H4アップレギュレーションのメカニズムを解明する.
- この調節経路におけるマイクロRNAの役割を調査する.
主な方法:
- B7-H4発現を検知する
- RT-qPCRでマイクロRNAをスクリーニングする.
- miR-140の結合とプロモーターの活性を確認するための二重ルシフェラーゼレポーターアッセイ.
- 染色体免疫降水 (ChIP) は,転写因子結合を特定する.
主要な成果:
- IL-10治療は,RAW264. 7細胞におけるmiR-140を低下させ,B7- H4を上調した.
- miR-140はB7-H4の3'UTRに直接結合し,その発現を抑制する.
- IL-10はSTAT5経由でmiR-140プロモーターの活性を抑制する.
- STAT5がmiR- 140プロモーターに結合することは,IL- 10の抑制作用に不可欠です.
結論:
- IL-10は,STAT5媒介によるmiR-140プロモーターの抑制によってmiR-140の発現を抑制する.
- これはマクロファージにおけるB7-H4の上昇を誘導する.
- スキストソミアシスの文脈でIL-10主導のB7-H4発現のための新しい分子メカニズムを特定します.
さらに関連する動画
07:09Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
7.6K
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
6.2K
関連する概念動画
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
